Beacon Enterprise Solutions Group, Inc.

Trading Symbol: BEAC.OB

Good and Great Morning!

BEAC’s corporate motto should be “Get ‘er done”.

To say that BEAC is just another, run-of-the-mill IT/Telecom firm—would be the furthest thing from the truth! continue

Winning Brands is currently a penny stock that has flirted with sub-penny stock  status very recently and then seemed like it was going to be  dollar stock…all in the space of a few weeks.

As you will see in the accompanying chart, Winning Brands, Inc. (WNDB) has been on a roller coaster ride of late.

I would look for some more confirmation that the stock is basing here at these levels.  It is highly volatile and appears to be under accumulation.

Winning Brands is one of those “take it on faith” stocks….because, there is not a great deal of  information available about them other than some PR, a website and a few filings.  They have made claims that they are going to be fully reporting.  I have talked to the company and they say that they are working aggressively towards that goal.

The company itself has a complete line of eco-friendly cleaning products that they are selling through retail outlets worldwide.  I have some experience in retail and while it is important for WNBD to get broad distribution, it is also important that they back up sales with ads, buzz, point-of-sale promotions….all stuff that costs money that WMBD doesn’t have yet.

They are on a fund raising campaign and will need every penny to make a splash in the market.  I did a very unscientific study and called my local paint store that carried WNBD’s products.  The counter person, at first, didn’t even know they carried it.  I insisted because I saw it on the site and she then located it.  I was hoping for a “gee whiz” testimonial about how this was the greatest product ever.  But, I didn’t get that.

That is, however, what WNBD needs to achieve….. A buzz that will carry the name of the company and its products to the four corners of the globe, literally.  Their “Extreme Home Makeover” tie-in is great, but where are the Billy Mays-type infomercials?  According to a December PR, they are working on a Direct Response ad program.  If that gets seen, it could be HUGE for the company.

WNBD might be a good little trader. It is building a following from what I read on the boards and it has a “story to tell”.  Any break below $.01 and the stock should be avoided.  But, if it can hold this level, then it might be a good entry point.  News and rumor are going to drive this company’s stock.

Be fast, be nimble with WNBD.

Good luck and good trading,

Jeffrey Dean

Note: Yahoo! Finance lists the name of WNBD as Global eTutor, Inc.  Google Finance and Pinksheets.com list it as Winning Brands, Inc.  This must be one of those corporate shells issues.

*******************************************************************

Reading a chart is sometimes like telling fortunes by reading tea leaves.  You may have a rare insight into a person or a situation by reading the leaves….or, you could just be full of crap!

I don’t think I am full of “it” when I recommend my members take a look at Microvision, Inc. (MVIS).  As recently as two months ago, the company’s stock hit a 52-week high of $5.75.  The stock couldn’t maintain its momentum and began to give most of the gain back and then recently announced a discounted equity offering that “finished ‘em off”.  It is a good thing to raise capital, but MVIS set the price for the stock with an offering priced at $3.00 (all to one institutional investor, by the way) and that predictably drove the price to that level.  It has recovered slightly, but still hovers around $3.19 as of Friday.

MVIS, especially with the latest capital raise, will have a strong balance sheet.  Even before this raise, the balance sheet was in good shape:  Good ratios, little or no debt, cash-in-the-bank, etc…  However, they are going to need every dollar with the burn rate that they are experiencing.  Great technology, but markets are only just beginning to be tapped and they are still in a big R & D push.

MVIS, the company, offers a technology platform that enables next generation display and imaging products.  Their main markets are displays in vehicles, projectors, wearable displays and bar code scanners.  I recommend that traders check out the MVIS Website. They have some cool technology that they think will be the standard in the years to come.

I also like the chart. The stock has taken its beating with the bad news (to traders) about the capital raise and the technical indicators are looking more favorable.

MVIS is a good radar stock, IMO.  The stock should be avoided for any break below the $3.05 range, but I don’t believe that it will break down.  The fact that an institutional investor is willing to pony up $9.3 MM for stock in a company that doesn’t make a profit, but has nice technology (and 115 patents at last count), is pretty impressive.

Long term this might be a good stock to own, but since I live in the short-term world….look for a ‘pop” in the near term.

Do your due diligence, but I like what I see with MVIS

Good luck and good trading

*****************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

I was doing some sector research tonight and came across a company that has a VERY interesting Chart:  Iridex Corporation (IRIX).  It just hit a 52-week high yesterday of $3.34 and the rise has been very steady and very strong over the past month.  Trading off a base of around $2.20, it has offered patient investors a one-month gain of over 50% and a 52-week gain of 227%.

And, what is not to like about IRIX? It is turning a profit, has cash-in-the-bank, has manageable debt and good coverage ratios.  As a recovering CPA, I actually am very impressed with the company.  Investors seem to be, too.  For a small cap (around $25MM) and tiny float of around 5.9 million shares, IRIX has really performed.

Iridex, the company, is a a global leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices.   They offer laser based solutions for multiple specialties including Aesthetic Medicine, Ophthalmology, Veterinary, and Otolaryngology.

My question is when will the stock chart crack? I am seeing a chart that is very overheated, has seen tremendous (for it) buying volume over the past month (i.e. rarely a down day).  See the chart for yourself:

This is a low-volume stock that has had a very prolonged run.  Will it crack?  I don’t know, but it bears watching.  The low volume and small float is worrisome to traders like me (I never like to get caught in a stock).  So, be careful.

There are two ways to play this stock: 1. Short - look for the break below the 50-day MA or weakness in the MACD or, 2. Long - This stock is building an audience and buyers are believing in management and its  prospects are looking too good.

If I was a betting man (I guess I am), I am thinking that IRIX should be watched for a near-term correction.

Good luck and good trading

******************************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Protectus Medical, Inc. (PTMD) is kind of a corny name….get it?  Protect Us!

But, it does fit in very nicely with their mission and their main product: a self-sheathing safety syringe.

PTMD is a long-term project, IMHO. The company came public in September backed by a strong PR program.  I mean, they were taking ads out in Barron’s….for goodness sake.  The stock came out at one dollar traded up to $1.70 on very strong volume and it has been a long, slow slide ever since.   Sellers have dominated and the stock has gotten knocked down to one-fifth of its high.

Does that mean that we should forget about them?  Are they done?  I don’t think so.

I did lots of research, called the IR people, read boring 10-Q’s and came out of it with an upbeat opinion of PTMD.  But, let’s talk about the negatives first:

Going Concern: Like every under-capitalized company, PTMD has got cash flow problems.  I take it for granted that they are looking for capital and that was confirmed by the IR people.

No manufacturing and No revenues: When I first did an alert on PTMD, it appeared that they were a great deal closer to actually manufacturing their “revolutionary device”.  It is still going to be some time in 2010 before they have units ready for sale.  The company is looking for both domestic and overseas production for their syringes.

Sellers are in control: It appears from PTMD’s chart that sellers are firmly in control and the downward pressure on the stock price is unmistakable!  When will the stock reach “sellers exhaustion” is difficult to guess (but it could be soon, IMO)

Now the positives:

The product: My sister is a registered nurse and, ironically, we have had conversations about needle sticks.  It is one of the most worrisome aspect of any medical professional’s job.  I can not speak to the efficacy of their product.  All I know is what I read on their site.  PTMD has taken steps to safeguard their technology both domestically and globally with an aggressive patent program.  Needle sticks is a problem in the medical profession and PTMD appears to have a viable product.  They have a video on their site showing the syringe in action(and how it compares with others on the market):  PTMD Syringe Very interesting viewing!

“Hospitals must take the safest device” : During my conversation with the IR people, they said something that I wrote down about hospitals taking the safest device.  What PTMD is offering, once it is on the market, could “sell like hotcakes”.   Frost and Sullivan, a market research firm, states that:

“Safety issues concerning regular syringes are driving the adoption of retractable syringes across the world. For instance, nearly 5.6 million healthcare workers in the U.S. suffer as many as 800,000 sharps injuries-mostly with needlesticks-each year. At this rate, around 2,100 health care professionals are likely to incur a needlestick-related injury every day. On an average, one out of every seven workers is accidentally struck by a contaminated sharp/needle and only one out of three incidents is reported. Companies participating in the world retractable syringes market are making use of these staggering statistics to convince end users on the advantages of using retractable syringes and thereby, increase their market penetration.”                                source:  Frost and Sullivan

I have not taken the time nor do I have the expertise to know if PTMD’s syringe is the best one available on the market, but they certainly believe so.

The Price - I was shocked when the IR people told me the costs of syringes.  A single syringe costs as low as 17 cents to as high as 75 cents…..what syringe companies lose in price they make up in volume, I guess.  One of the “knocks” that I have read against other “safety syringes” on the market are their cost.  PTMD is aware of this and plans on pricing their syringes on the lower end of that range (approx. 20 to 23 cents).  They believe that will alleviate the price objection when they are working with hospitals on accepting their syringes.

The Chart - The “falling knife” has landed…I think.  Since I own shares in PTMD, I have been watching it since almost the beginning.   What was a short term trade for me turned into a long term hold (Didn’t follow my own rules about stop losses).  Since I am in it, I think that now is a better time to watch PTMD.

PTMD might be prime for a short term bounce, but I would watch it long term to see if it can execute on its strategy.  It’s all just “smoke and mirrors” until they get their syringes on the market, but I think the potential of the stock makes is something that should be on the trading radar.  The stock is still trying to find a bottom, but IMO it’s not that far off.

Disclosure:  Long PTMD

The old axiom in automotive circles is that in order to gain power, you must sacrifice gas mileage. Another way to say it is that there is an inverse relationship between power and gas mileage.

Or, at least that USED TO BE the “old saying”.

My alert company today has developed a “game changing technology” that is operational and ready to hit the road.

That company is: NeoHydro Technologies (NHYT). continue